• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Muscular Atrophy, Spinal

Muscular Atrophy, Spinal - 11 Studies Found

Terminated : A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
: Muscular Atrophy, Spinal
: 2014-09-11
:
  • Drug: RO6885247 oral solution

Completed : A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Infants With Type1 Spinal Muscular Atrophy (Firefish)
: Muscular Atrophy, Spinal
: 2016-09-21
: Drug: RO7034067 RO7034067 will be administered orally.
Completed : A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Type 2 and 3 Spinal Muscular Atrophy Participants (Sunfish)
: Muscular Atrophy, Spinal
: 2016-09-19
:
  • Drug: Placebo Placebo will be

Completed : A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
: Muscular Atrophy, Spinal
: 2007-12-04
: Drug: Hydroxyurea
Completed : A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
: Muscular Atrophy, Spinal
: 2007-12-04
: Drug: Hydroxyurea
Completed : Pilot Study of Growth Hormon to Treat SMA Typ II and III
: Muscular Atrophy, Spinal
: 2007-09-12
:
  • Drug: somatotropin 0,015 mg/kg

Completed : Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.
: Healthy Volunteer, Muscular Atrophy, Spinal
: 2014-01-16
Active, not recruiting : International SMA Patient Registry
: Muscular Atrophy, Spinal
: 2007-04-24
Completed : A Study to Collect Blood Samples From Patients With Spinal Muscular Atrophy for Biomarker Analysis
: Muscular Atrophy, Spinal
: 2013-07-25
Active, not recruiting : A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Participants With Spinal Muscular Atrophy (SMA)
: Muscular Atrophy, Spinal
: 2015-12-01
: Drug: Olesoxime Participants will receive homogeneous suspension of olesoxime.
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.